New emerging areas of research and innovation around mapping systems can allow cardiologists to see the source of atrial fibrillation, and target the areas of the heart muscle that are causing the problems. If this new technology can help reveal the source, than doctors will only have to focus on the misfiring areas, and hence increase the success rates dramatically. Starting from 2009, Ken Londoner has been leading BioSig Technologies, a medical device company that is developing technology platforms designed to improve and assist electrophysiologists. According to analysts’ forecasts, the global market for EP devices will grow from $2.5 billion in 2012 to $5.5 billion by 2019, and thus it will become one of the fastest growing medical device segments.
In order to achieve advances in catheter ablation, medical device companies like the one founded by Londoner, are putting their trust and money in 3-D imaging which can hopefully help target the right areas for treatment. Although this technology has been around for a long time, experts say that now they will take 3-D technology to the next level and will not only see anatomy in 3-D, but they'll also be able to see the propagation of the electrical waves in 3-D. As executive chairman and director of BioSig, Ken Londoner has invested a lot in this emerging technology and is planning to move forward, hoping that complications can be reduced to less than 1 percent, which is a major improvement.
This page has tags:
This page references:
- Ken Londoner: New Tech Can Help Treat Atrial Fibrillation